Larvol Delta - CNS-Pharmaceuticals-To-Release-Interim-Data-By-The-End-Of-The-Year-For-Potential-Glioblastoma-Drug-Candidate

berubicin (RTA 744) - CNS Pharma, WPD Pharma

https://ir.cnspharma.com/news-events/press-releases/detail/175/cns-pharmaceuticals-to-release-interim-data-by-the-end-of

Nov 16, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next